Dev48
Language
  • About
  • Services
  • Industries
  • Technologies
  • Articles
  • Contacts
Book a call
    Home/Articles/Getinge invites fund managers analysts and media to q3 report 2026 conference ca
Dev48
info@dev48.org+375 29 320-40-96WhatsApp@isky_by

© 2026 · All rights reserved.

Getinge invites fund managers, analysts, and media to Q3 Report 2026 conference call

Фото: AS_Photography (Pixabay) — https://pixabay.com/photos/modern-technologies-marketing-1263422/

Source: Getinge•October 7, 2026 at 04:50 PM

Getinge invites fund managers, analysts, and media to Q3 Report 2026 conference call

Getinge will issue its Q3 Report 2026 on October 21, 2026, at 08.00 a.m. CEST, followed by a conference call at 10.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

Press Release Gothenburg, Sweden on October 7, 2026

Press release | 10/7/2026

Getinge will issue its Q3 Report 2026 on October 21, 2026, at 08.00 a.m. CEST, followed by a conference call at 10.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

Fund managers, analysts and media are invited to participate in the conference call.

To participate via telephone conference, please register via this link. After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.

During the conference call a presentation will be held. To access the presentation through webcast, please use this link. A recorded version can be accessed here for 3 years.

Contact information

David Kördel, Head of Investor Relations Phone: +46(0)10 335 0077 E-mail: david.kordel@getinge.com

About Getinge With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in 135 countries.

You are now leaving Getinge.com. You may access content that is not managed by the Getinge team, in which case Getinge can not be held responsible for the content.

← All articles

What this article says

More in HealthTech & MedTech

All →
The Shift to Proactive Patient Management
Athenahealth

The Shift to Proactive Patient Management

GE HealthCare Foundation announces 2026 grants to expand maternal and pediatric care in underserved communities
Ge Healthcare

GE HealthCare Foundation announces 2026 grants to expand maternal and pediatric care in underserved communities

GE HealthCare introduces new Imaging 360 features to simplify protocol management and support radiology workflows
Ge Healthcare

GE HealthCare introduces new Imaging 360 features to simplify protocol management and support radiology workflows

OCCLUDE Registry at SIR - Obsidio Conformable
Boston Scientific

OCCLUDE Registry at SIR - Obsidio Conformable

Anatomy Animation Animation- Obsidio™ Conformable Embolic
Boston Scientific

Anatomy Animation Animation- Obsidio™ Conformable Embolic

Setup Video - Obsidio™ Conformable Embolic
Boston Scientific

Setup Video - Obsidio™ Conformable Embolic

More from Getinge

Getinge establishes Sustainable Financing Framework
Getinge

Getinge establishes Sustainable Financing Framework

Getinge appoints Stacy Beske as President Acute Care Therapies
Getinge

Getinge appoints Stacy Beske as President Acute Care Therapies

Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction
Getinge

Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction

Nomination Committee appointed ahead of Getinge’s Annual General Meeting 2027
Getinge

Nomination Committee appointed ahead of Getinge’s Annual General Meeting 2027

Getinge brings its smallest Edi catheter to the U.S. market following FDA clearance
Getinge

Getinge brings its smallest Edi catheter to the U.S. market following FDA clearance

Getinge announces departure of Eric Honroth, President Life Science
Getinge

Getinge announces departure of Eric Honroth, President Life Science